Reply to “Rationalizing and mitigating the risk of live-attenuated dengue vaccines”

dc.contributor.authorRattanaumpawan P.
dc.contributor.correspondenceRattanaumpawan P.
dc.contributor.otherMahidol University
dc.date.accessioned2025-12-26T18:29:13Z
dc.date.available2025-12-26T18:29:13Z
dc.date.issued2025-01-01
dc.identifier.citationInternational Journal of Infectious Diseases (2025)
dc.identifier.doi10.1016/j.ijid.2025.108243
dc.identifier.eissn18783511
dc.identifier.issn12019712
dc.identifier.pmid41276010
dc.identifier.scopus2-s2.0-105025114301
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/113666
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.subjectMedicine
dc.titleReply to “Rationalizing and mitigating the risk of live-attenuated dengue vaccines”
dc.typeLetter
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105025114301&origin=inward
oaire.citation.titleInternational Journal of Infectious Diseases
oairecerif.author.affiliationSiriraj Hospital

Files

Collections